Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Nearly 400,000 turn to urgent care or GP as pharmacies cannot fill their prescriptions

Liberal Democrats calls for urgent action to ensure patients can access the medication they desperately need and to help struggling pharmacies stay open

Nearly 400,000 turn to urgent care or GP as pharmacies cannot fill their prescriptions

Pressures with managing medicines shortages impacting mental health of pharmacy staff

gettyimages

Patients are struggling to access their prescriptions as pharmacies grapple with financial strain and ongoing medicine shortages.

Analysis of the ONS Health Insight Survey by the Liberal Democrats revealed that an estimated 382,000 adults visited their GP or an urgent care service in December alone because their usual pharmacy was unable to fill their NHS prescription.


In addition, a further 269,000 took no further action after they couldn’t get their prescription between 10 December and 1 January.

Overall, an estimated 3 million people—13.5% of those using prescription services—reported experiencing issues with obtaining their medication during this period.

A significant number, 426,000 people, were forced to visit multiple pharmacies to secure their prescription, while 336,000—more than one in ten affected patients—had to wait over a week to resolve their medication issue.

Furthermore, an estimated 853,000 people expressed dissatisfaction with the NHS pharmacy service they had received.

Liberal Democrat Hospitals and Primary Care spokesperson Jess Brown-Fuller MP warned that frontline health services are “at breaking point” with devastating consequences for patients.

“We have heard from countless people who are struggling to access their prescriptions when they need them with many turning to A&E or their GP or even going without the medicine they need to get through their daily lives,” he said.

“All this piles pressure on our hospitals and primary care services that are already at the brink.”

The MP accused the Conservative Party of “shameful neglect” that has punished patients in this way, and condemned the Labour government’s “total lack of urgency” as “inexcusable.”

“It is not good enough for the government to sit back and watch as people can't access the medicines they need,” he said.

He emphasised the need for urgent action to ensure “patients can access the medication they desperately need and struggling pharmacies can keep their doors open.”

The Liberal Democrats pointed to rising medicines purchasing costs as a major factor driving financial pressures for pharmacies, many of which are at risk of closure.

An analysis by the National Pharmacy Association (NPA) found that 87% of council areas have lost at least one pharmacy in the past two years.

Meanwhile, findings from the Royal Pharmaceutical Society’s (RPS) latest Workforce Wellbeing Survey paint a troubling picture of the impact of medicine shortages on pharmacy teams.

More than 6,500 pharmacists and pharmacy technicians took part in the survey, with over 40% believing that medicine shortages have put patients at risk, potentially causing worsening health conditions, flare-ups, relapses, or a reduced quality of life.

In the past 12 months, 56% of respondents reported that pressures with managing medicines shortages had directly impacted their mental health and wellbeing, and 49% said they had experienced verbal abuse due to medicine shortages.

Additional stress factors included inadequate staffing, lack of work-life balance, increased financial pressures, lack of protected learning time, lack of colleague or senior support, and long working hours.

The survey further revealed that 87% of respondents were at high risk of burnout, while only 21% felt their mental health was a priority in the workplace.

“Pharmacy teams want to do everything possible to provide the medicines their patients need, and it’s deeply distressing when they can’t,” said RPS President Professor Claire Anderson.

“This sense of ‘moral injury’ – of knowing what patients need but being unable to deliver it due to circumstances beyond their control – is taking a heavy toll on their wellbeing,” she added.

Professor Anderson stressed the urgent need for solutions, not only for the wellbeing of the workforce but for ensuring safe and effective patient care.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less